Financial Statement Analysis

Total Page:16

File Type:pdf, Size:1020Kb

Financial Statement Analysis 1 Accounting 516 Spring Ram TS Ramakrishnan 2018 Financial Statement Analysis tiny.cc/FSA516 Accounting Standards Code: http://aaahq.org/ascLogin.cfm AAA51452. Wharton Service: http://wrds-web.wharton.upenn.edu/wrds/ afa2017 2 Accounting 516 Ram TS Ramakrishnan Financial Statement Analysis Instructor: Ram T. S. Ramakrishnan Office hours: Mondays and Yhursdays 2-5 pm. 2300, University Hall; [email protected] (312) - 996 - 3270 Required Materials: Financial Statement Analysis and Valuation by Peter D. Easton, Mary Lea McAnally, Gregory A. Sommers and Xiao-Jun Zhang Publisher: Cambridge Business Publishers; 4th edition ISBN-10: 1618531042 ISBN-13: 978-1618531049 Please make sure you can access a copy of Pfizer-10-K-2 to the class every day. Accounting Standards Code: http://aaahq.org/ascLogin.cfm AAA51452. Wharton Service: http://wrds-web.wharton.upenn.edu/wrds/ afa2017 Learning Objectives At the end of the course, you will be able to identify the impact accrual accounting on financial statements. analyze how margins, turnover, operating and financial leverage affect return on equity distinguish the impact of alternate accounting methods on financial statements. analyze how alternate corporate structures and investments affect financial statements. The recent corporate accountability crises has focused the world's attention on what accounting reports can do and what it can not do. Accounting failures at AIG, Enron, WorldCom and numerous other firms has led to extensive reforms in the US. The Sarbanes-Oxley (2002) act includes many accounting and disclosure reforms. But these actions could not prevent the options backdating scandals of 2006- 07 or fair value crisis relating the lending crisis of 2008. Throughout these crises what was surprising was the lack of understanding of GAAP and financial statements by many Board of Directors and Wall Street Analysts. If one thinks of financial reporting as a game - the executives will try to put the firm in the best light under what GAAP allows, how could you as an analyst disentangle the information. This course will emphasize the use of published financial reports by decision makers external to the firm (e.g. investors and creditors). Within decision contexts, the usefulness of financial filings and empirical research in accounting and finance will be analyzed. You will gain insights into the intense controversies surrounding the promulgation of disclosure standards and you will better understand how you may influence and be influenced by this essentially political process. If you are interested in careers in investment banking, financial audits, equity research, private equity, risk analysis and in pursuing the CFA designation, this course is a must.. AAA51452 FUEy33Q You will also acquire knowledge about how capital markets react to accounting disclosures. What is 3 (and will be) the value impact of earnings, book value and other accounting information? We will consider the traditional models and also newer insights into the pricing of securities using free cash flows and economic value added. If somebody showed the statements of a firm to you, you should be to able to see the "inside" story, ask the right questions and value the firm. The dominant approach in this course will be fundamental analysis. Bankruptcy and risk prediction models and bond rating models that use accounting numbers will be evaluated. We will look at studies that try to explain variations in the P/E ratios and price to book ratios and earnings response coefficients. Studies that document market anomalies based on accounting numbers will be discussed last. You will also learn how to use large data bases like Compustat (for accounting information), CRSP (for stock prices and returns) and IBES (for analyst estimates). UICActg18 The standard prerequisites for this course are two courses in financial accounting (for example Accounting 500 and 502). If you have taken only Accounting 500, you may still take this course, if you are willing to put in some extra effort. Please fill the "Accounting Prerequisite Exemption Form" and bring it to the class to get my approval. The course uses real financial statements extensively and you should be familiar with annual reports. As a part of the course you will be analyzing and valuing one company (a company of your choice) thoroughly. For this, you may have to download 10 - Ks and other SEC filings. Course Requirements Individual Final 145 Midterm 115 Quiz: (out of 6) 5 • 20 100 In Groups Cases 4 80 Current Developments 3 30 Project 30 Total 500 4 Accounting 516 Ram TS Ramakrishnan Financial Statement Analysis For the latest version check tiny.cc/FSA516 # Thu Assignment Due 1 18-Jan Thu 2 25-Jan Thu Current Dev1 SEC, Ernst & Young @ Bally 3 1-Feb Thu Quiz 1 Cash Flow 4 8-Feb Thu Quiz 2 Profitability 5 15-Feb Thu Case 1 Walmart • Target 6 22-Feb Thu Quiz 3 Inventories 7 1-Mar Thu Case 2 Nucor 8 8-Mar Thu Quiz 4 LT Assets • Tax • Lease 9 15-Mar Thu Exam Midterm 10 22-Mar Thu Current Dev2 Worldcom 11 5-Apr Thu Case 3 Texaco 12 12-Apr Thu Quiz 5 Investments 13 19-Apr Thu Case 4 HomeDepot 14 26-Apr Thu Current Dev3 Lehman 15 3-May Thu Quiz 6 Debt and Equity Markets 16 3-May Thu Exam Final 1 Introduction Class discussion: Chapter 1, 01-Notes • First-class • Notes and Readings 01 Introduction Notes.pdf • 09 Handout.pdf • 51 Groupon Q.pdf • Book1.xlsx • Checklist 10K ¤ Credit Suisse.pdf • Economic & Institutional Setting.pdf • Links.docx • Pfizer 15 10K 1 Items.pdf • Pfizer 15 10K 2 Financial Review.pdf • Pfizer 15 10K 3 Financials.pdf • Pfizer 15 10K 4 Exhibit 21.pdf • Pfizer 15 Proxy Statement.pdf • Present Value 2 To 11.pdf • Present Value 4 To 12 11half.pdf • Present Value 7 To 14.pdf Groupon-Q • 10-K-Ending-123111 • S-1-August-10-2011 • S-1-September-23-2011 2 Cash Flow Analysis Accrual concept of income• Analysis of cash flow information• Effect of Acquisitrions• Class discussion: Appendix B • Pfizer-10-K: Construct the cash flow statement using other statements • Was Apple conservative or aggressive for revenue recognition • Analyze Lucent’s receivables 5 Notes and Readings 02 Notes Cash Flow • 51 AAPL Deferred Revenue • 52 Pfizer Cash Flows • 91 Deferrals and Accruals • 92 Bad Debts & CFO • 93 PP & E • ASC 230 Statement Of Cash Flows • Cash Flow Classification FASB Issues ¤ Deloitte • Cash Flow Statement ¤ Penman • Dividends and Interest ¤ McGladrey • Pfizer 15 10k 1 Items • Pfizer 15 10k 2 Financial Review • Pfizer 15 10k 3 Financials • Pfizer 15 10k 4 Exhibit 21 • Pfizer 15 Proxy Statement • Pfizer Analysis \AAPL\0 Apple Analysis • AAPL 08 10k Extract • AAPL 08 10k • AAPL 09 10k Extract • AAPL 09 10k Revised Extract • AAPL 09 10k Revised • AAPL 09 10k • AAPL 10 10k • AAPL EITF Lobbying • Accounting Shift Would Lift Tech Profits ¤ WSJ • Apple Gets a Bruise by Blaming ¤ WSJ • Apples Real Earnings Up Almost 125% ¤ Fortune • Apple’s Retail Army ¤ NYT • Day Apple Released Its iPhone Revenue Bomb ¤ Fortune • EA Shows Some Signs Of Progress Amid Loss [Q] • How Apple Sidesteps Billions In Taxes • How To Spend Apple's Cash • Revenue Stream; Spotlight On Apple's Hidden = ¤ Fortune \Chevron\Chevron CFO Needs To Boost Cash • Chevron CFO Needs To Boost Cash • Conference Call 2015 • Earnings Press Release • Transcript 2015 05 \Lucent\Earnings Management The Case Of Lucent Technologies • Lucent 1999 10k Valuation • Lucent 1999 10k • Lucent 1999 Financials §¤• Lucent 2000 Cash flow • Lucent 2000 • Lucent 99 Analysis • Lucent Slashes First Quarter Outlook Erases Revenue From Latest Quarter ¤ WSJ • The Ins & Outs Of Cash Flow Bloomberg \Methodology CF\Balance Sheet Changes To CF Statement • Cash Cushion How Big Is The = • Cash Flows In 7 Steps • Dividends & Interest Received ¤ McGladrey • EY Cash Flows • Puzzle Of The Cash Flow Statement \Operating CF Boosts\Cash Flow Hocus Pocus • Cash Flow Never Lies Or Does It Outside Audit • Operating Cash Flow Change In Accounting For \Other Cases CF\09 Handout • Baxter 10k Extract • Baxter 10k Financials • Baxter 10k Other pages • Baxter 10K • Baxter Analysis • Baxter profit up 7% in 4 \Readings CF\Altria Cigarette Lawsuits Light Up Kraft Spinoff Talk • Altria Ready To Consider Next Breakup [Q] • Cash Flow A Better Way To Know Your Bank ¤ CFO • Cash Flow Reigns Once Again • Credit Woes Hit In Unlikely Places ¤ WSJ • EBITDA Warts & All • Financial Statement Risk How To Minimize = ¤ CGMA • Free Cash Flow; Voluntary Disclosure Of = • Hertz Tries Too Hard To Buff Up Its Statements • History Of Telecoms • In India Clues Unfold To A Fraud Framework • Is Target Corp's Credit Too Generous • Looking For Cable's Moment In The Sun • Microsoft CFO ¤ McKinsey • Microsoft Dividend • On Or Of Where Accounting Meets Language • Raising Cash; Banks Offer Smaller Companies An Indirect Route To = ¤ WSJ • Steve Jobs Bonus Feb 2000 ¤ SJM News • Uncovering cash & insights from working capital ¤ McKinsey • Viacom's Dividend Loyalties ¤ WSJ • What Constitutes Cash; Firms Ponder = • Why Gadget Warranties Are (Almost) Never Worth It ¤ WSJ • Z How ATMs Work • Z Payables Cartoon 1 • Z Payables Cartoon 2 \Stock options\Options Rule Also Hits Operating Cash Flow • Options Rule Could Hit Cash Flows • Stock Options Pad Cash Flow Of Soaring Technology Issues ¤ WSJ \Too-Much-Cash\Apple’s Cash Pile Triggers Talk of Returns and Acquisitions The CFO Report ¤ WSJ • Buyers Of Corporate Debt Are Other Corporations = ¤ WSJ • Corporate Cash Umbrellas Too Big For This Storm ¤ WSJ 09 • Deloitte Cash Paradox • Firms Keep Stockpiles Of 'Foreign' Cash In US • How Will Cash Rich Firms Share Profits 13 • Many US Companies Sitting Tight On Plump Cash Cushions • Record Cash Hoard Concentrated • Suddenly Flush Airlines Debate How To Use Cash • Too Much Cash 04 • Top Us Firms Are Cash Rich Abroad 12 • We Don’t Want Your Cash ¤ WSJ • Where To Steer Cashq 6 3 Profitability Common size statements; Operating Return; Categories of ratios; Integrated ratio analysis.
Recommended publications
  • In the United States District Court for the Northern District of Illinois Eastern Division Surfside Non-Surgical Orthopedics, P
    Case: 1:18-cv-00566 Document #: 47 Filed: 06/25/18 Page 1 of 31 PageID #:227 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION SURFSIDE NON-SURGICAL ) ORTHOPEDICS, P.A., individually and ) on behalf of all others similarly-situated, ) ) Plaintiff, ) ) v. ) Case No.: 1:18-cv-00566 ) ALLSCRIPTS HEALTHCARE ) Hon. Sara L. Ellis SOLUTIONS, INC., ) ) Hon. Jeffrey Cole, Magistrate Defendant. ) MEMORANDUM IN SUPPORT OF DEFENDANT ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.’S MOTION TO DISMISS THE CLASS ACTION COMPLAINT Case: 1:18-cv-00566 Document #: 47 Filed: 06/25/18 Page 2 of 31 PageID #:228 TABLE OF CONTENTS INTRODUCTION......................................................................................................................... 1 RELEVANT FACTS .................................................................................................................... 2 I. THE PARTIES ...................................................................................................................... 2 II. THE ATTACK ON THE LLC HOSTING ENVIRONMENT ......................................... 4 III. PLAINTIFF’S CONTRACT WITH LLC .......................................................................... 4 IV. PLAINTIFF’S ALLEGED CLAIMS AGAINST INC. ...................................................... 5 ARGUMENT ................................................................................................................................. 5 I. PLAINTIFF’S CLAIMS AGAINST INC. MUST BE DISMISSED ...............................
    [Show full text]
  • Usef-I Q2 2021
    Units Cost Market Value U.S. EQUITY FUND-I U.S. Equities 88.35% Domestic Common Stocks 10X GENOMICS INC 5,585 868,056 1,093,655 1ST SOURCE CORP 249 9,322 11,569 2U INC 301 10,632 12,543 3D SYSTEMS CORP 128 1,079 5,116 3M CO 11,516 2,040,779 2,287,423 A O SMITH CORP 6,897 407,294 496,998 AARON'S CO INC/THE 472 8,022 15,099 ABBOTT LABORATORIES 24,799 2,007,619 2,874,948 ABBVIE INC 17,604 1,588,697 1,982,915 ABERCROMBIE & FITCH CO 1,021 19,690 47,405 ABIOMED INC 9,158 2,800,138 2,858,303 ABM INDUSTRIES INC 1,126 40,076 49,938 ACACIA RESEARCH CORP 1,223 7,498 8,267 ACADEMY SPORTS & OUTDOORS INC 1,036 35,982 42,725 ACADIA HEALTHCARE CO INC 2,181 67,154 136,858 ACADIA REALTY TRUST 1,390 24,572 30,524 ACCO BRANDS CORP 1,709 11,329 14,749 ACI WORLDWIDE INC 6,138 169,838 227,965 ACTIVISION BLIZZARD INC 13,175 839,968 1,257,422 ACUITY BRANDS INC 1,404 132,535 262,590 ACUSHNET HOLDINGS CORP 466 15,677 23,020 ADAPTHEALTH CORP 1,320 39,475 36,181 ADAPTIVE BIOTECHNOLOGIES CORP 18,687 644,897 763,551 ADDUS HOMECARE CORP 148 13,034 12,912 ADOBE INC 5,047 1,447,216 2,955,725 ADT INC 3,049 22,268 32,899 ADTALEM GLOBAL EDUCATION INC 846 31,161 30,151 ADTRAN INC 892 10,257 18,420 ADVANCE AUTO PARTS INC 216 34,544 44,310 ADVANCED DRAINAGE SYSTEMS INC 12,295 298,154 1,433,228 ADVANCED MICRO DEVICES INC 14,280 895,664 1,341,320 ADVANSIX INC 674 15,459 20,126 ADVANTAGE SOLUTIONS INC 1,279 14,497 13,800 ADVERUM BIOTECHNOLOGIES INC 1,840 7,030 6,440 AECOM 5,145 227,453 325,781 AEGLEA BIOTHERAPEUTICS INC 287 1,770 1,998 AEMETIS INC 498 6,023 5,563 AERSALE CORP
    [Show full text]
  • ANA Integrated Marketing Members-Only Conference at Microsoft Advertising
    ANA Integrated Marketing Members-Only Conference at Microsoft Advertising June 4, 2013 | Chicago, Ill. Join the conversation on Twitter by using #ANAmarketers Upload photos and video, and make comments on facebook.com/ANA Table of Contents ANA Integrated Marketing Members-Only Conference at Microsoft Advertising Agenda ............................................................................ pg 1 Speaker Bios .................................................................... pg 3 Attendees ........................................................................ pg 6 ANA Information .............................................................pg 10 www.ana.net Agenda ANA Integrated Marketing Members-Only Conference at Microsoft Advertising Tuesday, June 4 Breakfast (8:15 a.m.) CARS.COM “NO DRAMA” APPROACH TO MULTISCREEN MAYHEM: INTEGRATED MARKETING CREATING ENGAGING CONTENT ACROSS MULTIPLE SCREENS General Session (9:00 a.m.) Cars.com’s 2013 Super Bowl ad kicked off the organization’s first truly integrated More consumers own upwards of four COCA-COLA LETS FANS DECIDE THE marketing campaign spanning all audi- connected devices, relating with content ENDING OF THEIR BIG GAME CAMPAIGN ences: consumers, customers, the industry, in a way that was never before possible. and employees. All centered around one While marketers are poised to reap the After their award-winning Polar Bowl BIG IDEA: the campaign drives a consistent benefit of more touchpoints across screens, campaign in Super Bowl 2012, Coca-Cola message across all consumer and
    [Show full text]
  • First Chair Awards & Conference
    FIRST CHAIR AWARDS CONFERENCE & GALA AUGUST 28, 2019 | CHICAGO, IL SPONSOR PROSPECTUS FIRST CHAIR AWARDS PRELIMINARY AGENDA Now in its ninth year, the annual First Chair awards program recognizes America’s WEDNESDAY, AUGUST 28, 2019 most innovative and accomplished in-house counsel for their achievements and significant contributions to the legal community. This full-day conference 8:30 a.m. - 9:00 a.m. | Registration Opens program, followed by an evening awards gala, has become the must-attend 9:00 a.m. - 9:30 a.m. | Welcome event for in-house counsel and their partners in the private legal community. 9:30 a.m. - 11:15 a.m. | General Counsel Roundtable Attended by more than 400 attorneys from around the country this event will 11:30 a.m. - 1:00 p.m. | Lunch/Keynote honor in-house counsel, from some of the country’s most recognized companies, 1:15 p.m. - 2:15 p.m. | Breakout Sessions that have made significant contributions to the legal community. 2:20 p.m. – 3:20 p.m. | Breakout Sessions The event includes a full day of CLE programming presented by First Chair faculty 3:20 p.m. - 3:35 p.m. | Networking Break for our in-house counsel community and select sponsors. The full-day event 3:35 p.m. - 4:35 p.m. | Breakout Sessions will include a General Counsel Panel followed by a private luncheon. Thereafter, attendees will be able to choose from a number of Breakout Sessions led by top 4:40 p.m. - 5:40 p.m. | Breakout Sessions law firm practitioners and members of the in-house community.
    [Show full text]
  • Membership List; Russell 2000 Index
    Russell US Indexes Membership list Russell 2000® Index Company Ticker Company Ticker 1-800-FLOWERS.COM CL A FLWS AFC GAMMA AFCG 1LIFE HEALTHCARE ONEM AFFIMED N.V. AFMD 1ST SOURCE SRCE AGEAGLE AERIAL SYSTEMS UAVS 22ND CENTURY GROUP INC. XXII AGENUS AGEN 2U TWOU AGILITI AGTI 3-D SYSTEMS DDD AGILYSYS AGYS 4D MOLECULAR THERAPEUTICS FDMT AGIOS PHARMACEUTICALS AGIO 89BIO ETNB AGREE REALTY ADC 8X8 EGHT AIR TRANSPORT SERVICES GROUP ATSG 9 METERS BIOPHARMA INC NMTR AKEBIA THERAPEUTICS AKBA 908 DEVICES MASS AKERO THERAPEUTICS AKRO A10 NETWORKS ATEN AKOUOS AKUS AAON INC AAON AKOUSTIS TECHNOLOGIES INC AKTS AAR CORP AIR AKOYA BIOSCIENCES AKYA ABERCROMBIE & FITCH A ANF ALAMO GROUP ALG ABM INDUSTRIES INC ABM ALARM.COM HOLDINGS ALRM ACACIA RESEARCH - ACACIA TECHNOLOGIES ACTG ALBANY INTERNATIONAL A AIN ACADEMY SPORTS AND OUTDOORS ASO ALBIREO PHARMA ALBO ACADIA PHARMACEUTICALS ACAD ALDEYRA THERAPEUTICS ALDX ACADIA REALTY AKR ALECTOR ALEC ACCEL ENTERTAINMENT (A) ACEL ALERUS FINANCIAL CORP. ALRS ACCELERATE DIAGNOSTICS AXDX ALEXANDER & BALDWIN INC. ALEX ACCO BRANDS ACCO ALEXANDERS INC ALX ACCOLADE ACCD ALIGNMENT HEALTHCARE ALHC ACCRETIVE HEALTH RCM ALIGOS THERAPEUTICS ALGS ACCURAY ARAY ALKAMI TECHNOLOGY ALKT ACI WORLDWIDE ACIW ALKERMES PLC ALKS ACLARIS THERAPEUTICS ACRS ALLAKOS ALLK ACUSHNET HOLDINGS GOLF ALLEGHENY TECHNOLOGIES ATI ACUTUS MEDICAL AFIB ALLEGIANCE BANCSHARES ABTX ADAPTHEALTH AHCO ALLEGIANT TRAVEL ALGT ADDUS HOMECARE ADUS ALLETE ALE ADICET BIO INC ACET ALLIED MOTION TECHNOLOGIES AMOT ADIENT PLC ADNT ALLOGENE THERAPEUTICS ALLO ADTALEM GLOBAL EDUCATION
    [Show full text]
  • Profunds Semiannual Report
    Toppan Merrill - ProFunds Funds VP Main Semi-Annual Report [Funds] 06-30-2021 ED [AUX] | bliteck | 24-Aug-21 00:06 | 21-1908-3.aa | Sequence: 1 CHKSUM Content: 54117 Layout: 6120 Graphics: 61486 CLEAN Semiannual Report JUNE 30, 2021 ProFunds VP Access VP High Yield Short Small-Cap Asia 30 Small-Cap Banks Small-Cap Growth Basic Materials Small-Cap Value Bear Technology Biotechnology Telecommunications Bull UltraBull Consumer Goods UltraMid-Cap Consumer Services UltraNasdaq-100 Dow 30 UltraShort Dow 30 Emerging Markets UltraShort Nasdaq-100 Europe 30 UltraSmall-Cap Falling U.S. Dollar U.S. Government Plus Financials Utilities Government Money Market Health Care Industrials International Internet Japan Large-Cap Growth Large-Cap Value Mid-Cap Mid-Cap Growth Mid-Cap Value Nasdaq-100 Oil & Gas Pharmaceuticals Precious Metals Real Estate Rising Rates Opportunity Semiconductor Short Dow 30 Short Emerging Markets Short International Short Mid-Cap Short Nasdaq-100 JOB: 21-1908-3 CYCLE#;BL#: 7; 0 TRIM: 8.25" x 10.75" AS: New York: 212-620-5600 COLORS: ~note-color 2, Black GRAPHICS: ProFunds_CVR_logo_k.eps, ProFunds_FC_art_k.eps V1.5 Toppan Merrill - ProFunds Funds VP Main Semi-Annual Report [Funds] 06-30-2021 ED [AUX] | bliteck | 24-Aug-21 00:06 | 21-1908-3.ac | Sequence: 1 CHKSUM Content: 53432 Layout: 22726 Graphics: 0 CLEAN Table of Contents 1 Message from the Chairman 188 ProFund VP Short Emerging Markets 3 Financial Statements and 192 ProFund VP Short International Financial Highlights 196 ProFund VP Short Mid-Cap 4 ProFund Access VP High Yield
    [Show full text]
  • Registration List Registered Guests
    DLA PIPER GLOBAL WOMEN’S LEADERSHIP SUMMIT SEPTEMBER 19-20, 2016 • THE RITZ-CARLTON CHICAGO REGISTRATION LIST REGISTERED GUESTS FIRST NAME LAST NAME TITLE COMPANY Jennifer Adams Senior Corporate Counsel USG Corporation Robyn Alexander Associate General Counsel, Real Estate Sears Holdings Corporation Yael Aufang Associate General Counsel Kaplan, Inc. Ines Bahachille Vice President, Legal and Counsel Diageo Kathleen Barlow Senior Vice President Marsh Angela Barnes Assistant General Counsel Velocitel Juana Barrera Associate General Counsel US Foods Shivani Bautista Attorney (International) United Airlines Rebecca Bedno Chief Counsel, Commercial Becton, Dickinson & Company Susan Bell Executive Vice President and General Counsel The Chamberlain Group Renee Betzelos Managing Principal ProTen Realty Group Wenyu Blanchard Senior Counsel Kraft Foods Group Kathleen Boege General Counsel Wintrust Financial Corporation Iyandra Bryan Managing Director Amicorp Group Anna Burgett Counsel Guaranty Commercial Title Marta Carreira-Slabe Chief Counsel Aon Corporation Catherine Casey General Counsel Baker Tilly Virchow Krause Clarissa Cerda General Counsel Pindrop Security Diana Chafey Executive Vice President and General Counsel The Warranty Group Lynn Charytan Executive Vice President and General Counsel Comcast Cable Shannon Clark Senior Counsel CB Richard Ellis Director, Information Management and Senior Kelly Clay GlaxoSmithKline Counsel Brandie Clevenger General Counsel Newgistics Katie Colendich Associate General Counsel HP Rebecca Collins Associate
    [Show full text]
  • Daniel Taubenfeld, Et Al. V. Career Education Corporation, Et Al. 03-CV-8884-Memorandum Opinion and Order
    UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION DANIEL TAUBENFELD, Individually and ) On Behalf of All Others Similarly Situated, ) ) Plaintiff, ) ) vs. ) No. 03 C 8884 ) Judge Joan H. Leticow CAREER EDUCATION CORPORATION, ) JOHN M. LARSON and PATRICK K. PESCH, ) ) Defendants. ) MEMORANDUM OPINION AND ORDER Lead plaintiff, Thomas Schroder, individually and on behalf of a class of purchasers of the securities of defendant Career Education Corporation ("CEC") between January 28, 2003 and December 2, 2003 (the "Class Period"), filed this lawsuit alleging that defendants, CEC, John M. Larson ("Larson"), and Patrick K. Pesch ("Pesch") (1) violated § 10(b) of the Securities Exchange Act of 1934, 15 U.S.C. § 78j(b), and Rule 10b-5 promulgated under § 78j(b); and (2) violated § 20(a) of the Securities Exchange Act of 1934, 18 U.S.C. § 78t(a). Plaintiff has moved to modify the discovery stay imposed under the Private Securities Litigation Reform Act of 1995, 15 U. S.C. § 78u-4(b) ("PSLRA"). Defendants, in turn, have moved to dismiss the Amended Consolidated Complaint (the "Complaint") for failure to state a claim upon which relief may be granted under Rule 12(b)(6), Fed. R. Civ. P., and for failure to satisfy the pleading requirements of Rule 9(b), Fed. R. Civ. P., and the PSLRA. For the reasons set forth below, defendants' motion is granted without prejudice to plaintiff filing an amended complaint and plaintiff's motion is denied as moot. MOTION TO DISMISS STANDARDS A motion to dismiss under Federal Rule of Civil Procedure 12(b)(6) challenges the sufficiency of the complaint for failure to state a claim upon which relief may be granted.
    [Show full text]
  • Retirement System Investment Commission Annual Investment Report South Carolina Retirement System Investment Commission
    2013-2014 South Carolina Retirement System Investment Commission Annual Investment Report South Carolina Retirement System Investment Commission Annual Investment Report Fiscal Year Ended June 30, 2014 Capitol Center 1201 Main Street, Suite 1510 Columbia, SC 29201 Reynolds Williams, JD, CFP Chairman July 1, 2012- June 30, 2014 Table of Contents ChairmanReport...................................................................................................................1 Consultant’sLetter................................................................................................................5 Overview...............................................................................................................................7 Commission...........................................................................................................................8 PolicyAllocation..................................................................................................................11 ManagerReturns(NetofFees)............................................................................................12 SecuritiesLending................................................................................................................15 Expenses.............................................................................................................................16 AppendixA:SummaryScheduleofAssetsandDerivatives..................................................17 AppendixB:CashandCashEquivalentHoldings..................................................................18
    [Show full text]
  • George A. Hedick, Jr., Et Al. V. the Kraft Heinz Company, Et Al. 19-CV-01339-Memorandum Opinion and Order
    Case: 1:19-cv-01339 Document #: 310 Filed: 08/11/21 Page 1 of 50 PageID #:15132 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION GEORGE A. HEDICK, JR., et al., ) ) Plaintiffs, ) ) Case No. 19-cv-1339 v. ) Judge Robert M. Dow, Jr. ) THE KRAFT HEINZ COMPANY, et. al., ) ) Defendants. ) MEMORANDUM OPINION AND ORDER In this consolidated class actions securities case, arising out of the 2015 merger that created the Kraft Heinz Company, two motions to dismiss are before the Court. One is from the Kraft Heinz Company and a set of individual defendants who were executives and directors at the company [279], and the other is from a set of corporate entities (“3G,” for short) that effected the merger [281]. For the reasons set forth below, the Court denies both motions to dismiss [279, 281]. I. Background This securities class action stems from the 2015 merger of Kraft Foods Group, Inc. (“Kraft”) with The H.J. Heinz Company (“Heinz”) into the Kraft Heinz Company (“Kraft Heinz” or the “Company”). According to the amended complaint [274], the merger was orchestrated by 3G Capital Partners (“3G”), a private equity partnership with a history of implementing a zero- based-budgeting strategy at companies it owned to extract cost savings. Plaintiffs say, in short, that 3G and Kraft (which 3G controlled before the merger) touted synergies, efficiencies, and eliminating redundancies as the benefits of Kraft’s merger with Heinz, but after the companies combined, executives at Kraft Heinz realized there were fewer savings to be had from synergies Case: 1:19-cv-01339 Document #: 310 Filed: 08/11/21 Page 2 of 50 PageID #:15133 than they had expected, and certainly not on the level of the $1.5 billion they had suggested to investors.
    [Show full text]
  • First Chair Awards & Conference
    FIRST CHAIR AWARDS CONFERENCE & GALA AUGUST 26, 2020 | CHICAGO, IL SPONSOR PROSPECTUS FIRST CHAIR AWARDS PRELIMINARY AGENDA Now in its eleventh year, the annual First Chair awards program recognizes WEDNESDAY, AUGUST 26, 2020 America’s most innovative and accomplished in-house counsel for their achievements and significant contributions to the legal community. This full- 8:30 a.m. - 9:00 a.m. | Registration Opens day conference program, followed by an evening awards gala, has become the 9:00 a.m. - 9:30 a.m. | Welcome must-attend event for in-house counsel and their partners in the private legal 9:30 a.m. - 11:15 a.m. | General Counsel Roundtable community. 11:30 a.m. - 1:00 p.m. | Lunch/Keynote Attended by more than 400 attorneys from around the country this event will 1:15 p.m. - 2:15 p.m. | Breakout Sessions honor in-house counsel, from some of the country’s most recognized companies, that have made significant contributions to the legal community. 2:20 p.m. – 3:20 p.m. | Breakout Sessions 3:20 p.m. - 3:35 p.m. | Networking Break The event includes a full day of CLE programming presented by First Chair faculty 3:35 p.m. - 4:35 p.m. | Breakout Sessions for our in-house counsel community and select sponsors. The full-day event will include a General Counsel Panel followed by a private luncheon. Thereafter, 4:40 p.m. - 5:40 p.m. | Breakout Sessions attendees will be able to choose from a number of Breakout Sessions led by top 6:00 p.m.
    [Show full text]
  • Natixis Sustainable Future 2045 Fund Investments As of June 30, 2021 (Unaudited)
    Natixis Sustainable Future 2045 Fund Investments as of July 31, 2021 (Unaudited) Shares Security Description Market Value ($) % of Fund Common Stocks 56 Abbott Laboratories 6,775 0.08% 58 AbbVie, Inc. 6,745 0.08% 62 Accenture PLC, Class A 19,696 0.24% 40 Activision Blizzard, Inc. 3,345 0.04% 18 Acuity Brands, Inc. 3,157 0.04% 36 Adobe, Inc. 22,379 0.27% 49 Advanced Micro Devices, Inc. 5,203 0.06% 184 AECOM 11,585 0.14% 91 AES Corp. (The) 2,157 0.03% 32 Aflac, Inc. 1,760 0.02% 69 AGCO Corp. 9,116 0.11% 24 Agilent Technologies, Inc. 3,678 0.04% 10 Air Products & Chemicals, Inc. 2,910 0.04% 115 Akamai Technologies, Inc. 13,791 0.17% 20 Alaska Air Group, Inc. 1,161 0.01% 221 Alibaba Group Holding Ltd., Sponsored ADR 43,137 0.52% 341 Allscripts Healthcare Solutions, Inc. 5,824 0.07% 43 Allstate Corp. (The) 5,592 0.07% 897 Ally Financial, Inc. 46,070 0.56% 166 Alnylam Pharmaceuticals, Inc. 29,704 0.36% 27 Alphabet, Inc., Class A 72,752 0.88% 31 Alphabet, Inc., Class C 83,837 1.01% 23 Amazon.com, Inc. 76,535 0.92% 19 Amedisys, Inc. 4,952 0.06% 134 American Campus Communities, Inc. 6,742 0.08% 136 American Eagle Outfitters, Inc. 4,688 0.06% 140 American Electric Power Co., Inc. 12,337 0.15% 196 American Express Co. 33,424 0.40% 508 American International Group, Inc. 24,054 0.29% 48 American Tower Corp.
    [Show full text]